* Identification of CTX-M-β[<03B2>][<03B2>]-Lactamases in Escherichia coli from the Community - Hemavarna Tiruvury, M.D., fellow, Department of Medicine, Division of Infectious Disease

Research identified that the most prevalent antibiotic-resistant enzyme, CTX-M-15, in community-acquired e. coli (EC) is resistant to third generation antibiotics. This enzyme is responsible for resistance in β[<03B2>][<03B2>]-Lactam antibiotics like penicillin. Additionally, carbapenems were the only type of antibiotics that would be therapeutically effective in patients with EC that possess the CTX-M-15 enzyme.


* Clinician Documentation of Significant Electrocardiographic Findings in Adults Presenting to the Emergency Department with Dysrhythmias and/or Conduction Disorders- Nidhi Garg, M.D., resident, Department of Emergency Medicine

Research identified that electrocardiographs are not as likely to be documented in patients younger than 65 years of age and when patients are admitted with a non-cardiac diagnosis.

* Intensity-Modulated Radiation Therapy (IMRT) Reduces Toxicity Compared to Three-Dimensional Conformal Radiotherapy (3D-CRT) and Achieves Dose Escalation Safely with ADCT Simulation in Clinical Thoracic Radiation - Weisi Yan, M.D., resident, Department of Radiation Oncology

Research identified that intensity-modulated radiation therapy with the ability of four-dimensional CT imaging, which plans and executes radiation treatment to increase concentration on the tumor and decrease concentration near normal tissue, is significantly advantageous in the treatment of thoracic malignancies compared to 3D-CRT. The combination of 4-D imaging and concentrated therapy helps achieve dose escalation safely in patients receiving thoracic radiation and/or concurrent chemotherapy.

* A Case Report of Neuromyelitis Optica in a Pediatric Patient: Distinguishing Neuromyelitis Optica from Multiple Sclerosis - J. Cooperman, M.D., resident, Department of Pediatrics

Research identified that although Neuromyelitis Optica (NMO) presents many clinical similarities to multiple sclerosis (MS) and was previously under the spectrum of MS, it is a distinct disorder. It is important to distinguish between these disorders since treatment strategies differ. Drugs that prevent activity of the immune system, specifically, the humoral immune response, have become the therapy of choice in preventing NMO relapse.

The Lang Research Center was made possible through an endowment by long-time NYHQ benefactors Eugene Lang and the late Theresa Lang. Today, the Center has more than 120 active clinical study protocols.

New York Hospital Queens is a member of the NewYork-Presbyterian Healthcare System and is an affiliate of the Weill Medical College of Cornell University.

Back to HCB News

More HCB News